Skip to main content

Laryngectomy; Status

0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Atos Medical
Atos MedicalSweden - Horby
1 program
Provox LifeN/A2 trials
Active Trials
NCT06084611Completed80Est. Sep 2025
NCT04943731Completed48Est. Apr 2022
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
Provox Vega Voice prosthesisN/A1 trial
Active Trials
NCT05482815Unknown80Est. Jan 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Atos MedicalProvox Life
Atos MedicalProvox Life
UNION therapeuticsProvox Vega Voice prosthesis

Clinical Trials (3)

Total enrollment: 208 patients across 3 trials

Long Term Effects of Heat and Moisture Exchangers (HMEs)

Start: Mar 2024Est. completion: Sep 202580 patients
N/ACompleted

Day/Night Regimen With Provox Life Heat and Moisture Exchangers

Start: Jul 2021Est. completion: Apr 202248 patients
N/ACompleted
NCT05482815UNION therapeuticsProvox Vega Voice prosthesis

Evaluation of the Safety and Efficacy of Voice Prosthesis in Voice Reconstruction After Total Laryngectomy

Start: May 2021Est. completion: Jan 202480 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.